International phase 3 clinical trial for new melanoma treatment recruits first patients
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda
Read More
Tag: Moderna
NIHR reveals phase 1/2 trial to evaluate an investigational vaccine for mpox in the UK
More than 3,700 cases of mpox have been identified in the UK since May 2022
Read More
First UK patients receive experimental mRNA therapy for cancer in global trial
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
Read More
FDA approves Pfizer/BioNTech and Moderna’s adapted COVID-19 vaccines
The updated vaccines more closely target current circulating variants
Read More
Moderna cancer vaccine takes positive step
Company’s candidate, in combination with MSD’s Keytruda, receives PRIME designation
Read More
Moderna opts for Oxfordshire in quest for innovation
Vaccines developed at the facility will cover a wide range of respiratory diseases
Read More
Moderna becomes latest company to join the ABPI
Company becomes the latest member of the ABPI and galvanises the company’s UK connections
Read More
MHRA authorises Moderna’s omicron-containing bivalent booster
Study results show the candidate has demonstrated significantly higher antibodies against Omicron
Read More
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
Read More
US approval for J&J and Moderna COVID-19 boosters
EUA amendments ‘based on the available data and information’
Read More
Moderna to collaborate with AbCellera
Partnership aims to develop mRNA-encoded antibody therapeutics
Read More
Moderna submits its COVID-19 vaccine booster to the FDA
Trial showed ‘robust antibody responses’ against Delta variant
Read More
- MHRA approves new treatment for severe alopecia areata
- Aplagon doses first patient in phase 2a trial of APAC
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
